Item Type | Name |
Academic Article
|
Coexistent tardive dyskinesia and parkinsonism.
|
Academic Article
|
Motor, behavioral and pharmacologic findings in Tourette's syndrome.
|
Academic Article
|
Dystonia and tremor induced by peripheral trauma: predisposing factors.
|
Academic Article
|
Focal task-specific tremor and dystonia: categorization of occupational movement disorders.
|
Academic Article
|
Rett syndrome: qualitative and quantitative differentiation from autism.
|
Academic Article
|
Cranial-cervical dyskinesias: an overview.
|
Academic Article
|
Orofacial and other self-mutilations.
|
Academic Article
|
The phenomenology of tics.
|
Academic Article
|
Response and immunoresistance to botulinum toxin injections.
|
Academic Article
|
Tremor and longevity in relatives of patients with Parkinson's disease, essential tremor, and control subjects.
|
Academic Article
|
Outcome after stereotactic thalamotomy for dystonia and hemiballismus.
|
Academic Article
|
Peripherally induced tremor and parkinsonism.
|
Academic Article
|
Tourettism associated with Huntington's disease.
|
Academic Article
|
Neurogenic orthostatic hypotension: a double-blind, placebo-controlled study with midodrine.
|
Academic Article
|
Vascular progressive supranuclear palsy.
|
Academic Article
|
Post-traumatic movement disorders: central and peripheral mechanisms.
|
Academic Article
|
Psychogenic myoclonus.
|
Academic Article
|
Longitudinal experience with botulinum toxin injections for treatment of blepharospasm and cervical dystonia.
|
Academic Article
|
Tardive stereotypy and other movement disorders in tardive dyskinesias.
|
Academic Article
|
Neuropsychological functioning in cortical-basal ganglionic degeneration: Differentiation from Alzheimer's disease.
|
Academic Article
|
Clozapine for acute and maintenance treatment of psychosis in Parkinson's disease.
|
Academic Article
|
Emotional and functional impact of DNA testing on patients with symptoms of Huntington's disease.
|
Academic Article
|
Paroxysmal dyskinesias: clinical features and classification.
|
Academic Article
|
Outcome after stereotactic thalamotomy for parkinsonian, essential, and other types of tremor.
|
Academic Article
|
Ecstasy intoxication: an overlap between serotonin syndrome and neuroleptic malignant syndrome.
|
Academic Article
|
Botulinum toxin injection into vocal cord in the treatment of malignant coprolalia associated with Tourette's syndrome.
|
Academic Article
|
Cervical dystonia as the initial presentation of Huntington's disease.
|
Academic Article
|
Severe motor tics causing cervical myelopathy in Tourette's syndrome.
|
Academic Article
|
Long-term effects of tetrabenazine in hyperkinetic movement disorders.
|
Academic Article
|
Tics secondary to craniocerebral trauma.
|
Academic Article
|
Microelectrode-guided posteroventral pallidotomy for treatment of Parkinson's disease: postoperative magnetic resonance imaging analysis.
|
Academic Article
|
The G209A mutation in the alpha-synuclein gene is not detected in familial cases of Parkinson disease in non-Greek and/or Italian populations.
|
Academic Article
|
Multiple system atrophy: the putative causative role of environmental toxins.
|
Academic Article
|
Clinical correlates of vascular parkinsonism.
|
Academic Article
|
Comparison of mouse bioassay and immunoprecipitation assay for botulinum toxin antibodies.
|
Academic Article
|
The alien hand and related signs.
|
Academic Article
|
Exercise performance in those having Parkinson's disease and healthy normals.
|
Academic Article
|
Levodopa-induced dyskinesias treated by pallidotomy.
|
Academic Article
|
Botulinum toxin A in patients with oromandibular dystonia: long-term follow-up.
|
Academic Article
|
Delayed-onset progressive movement disorders after static brain lesions.
|
Academic Article
|
Essential tremor: clinical characteristics.
|
Academic Article
|
Propofol-induced dyskinesias in Parkinson's disease.
|
Academic Article
|
A randomized, double-blind, placebo-controlled study to evaluate botulinum toxin type A in essential hand tremor.
|
Academic Article
|
Re-emergence of childhood stuttering in Parkinson's disease: a hypothesis.
|
Academic Article
|
Efficacy and tolerability of a novel sublingual apomorphine preparation in patients with fluctuating Parkinson's disease.
|
Academic Article
|
Association of single-nucleotide polymorphisms of the tau gene with late-onset Parkinson disease.
|
Academic Article
|
Restless legs syndrome: clinicoetiologic correlates.
|
Academic Article
|
A novel sublingual apomorphine treatment for patients with fluctuating Parkinson's disease.
|
Academic Article
|
Exploring the relationship between Parkinson disease and restless legs syndrome.
|
Academic Article
|
Association of homozygous 7048G7049 variant in the intron six of Nurr1 gene with Parkinson's disease.
|
Academic Article
|
Familial essential tremor in 4 kindreds. Prospects for genetic mapping.
|
Academic Article
|
Tardive and idiopathic oromandibular dystonia: a clinical comparison.
|
Academic Article
|
Polymorphism of NACP-Rep1 in Parkinson's disease: an etiologic link with essential tremor?
|
Academic Article
|
Hemidystonia secondary to carotid artery gunshot injury.
|
Academic Article
|
Secondary paroxysmal dyskinesias.
|
Academic Article
|
Tourettism and dystonia after subcortical stroke.
|
Academic Article
|
H-reflex recovery curves differentiate essential tremor, Parkinson's disease, and the combination of essential tremor and Parkinson's disease.
|
Academic Article
|
Tetrabenazine treatment for Huntington's disease-associated chorea.
|
Academic Article
|
Thalamic surgery for movement disorders.
|
Academic Article
|
Neuropsychological outcome after unilateral pallidotomy for the treatment of Parkinson's disease.
|
Academic Article
|
Variability of the immunologic and clinical response in dystonic patients immunoresistant to botulinum toxin injections.
|
Academic Article
|
Computerized posturography analysis of progressive supranuclear palsy: a case-control comparison with Parkinson's disease and healthy controls.
|
Academic Article
|
Long-term efficacy of posteroventral pallidotomy in the treatment of Parkinson's disease.
|
Academic Article
|
Basal ganglia neuronal discharge in primary and secondary dystonia in patients undergoing pallidotomy.
|
Academic Article
|
Accuracy of the clinical diagnoses of Lewy body disease, Parkinson disease, and dementia with Lewy bodies: a clinicopathologic study.
|
Academic Article
|
Pallidotomy for generalized dystonia.
|
Academic Article
|
Posteroventral medial pallidotomy for treatment of Parkinson's disease: preoperative magnetic resonance imaging features and clinical outcome.
|
Academic Article
|
Concepts and methods in chronic thalamic stimulation for treatment of tremor: technique and application.
|
Academic Article
|
Dystonia in corticobasal degeneration.
|
Academic Article
|
Comparison of thalamotomy and pallidotomy for the treatment of dystonia.
|
Academic Article
|
9p monosomy in a patient with Gilles de la Tourette's syndrome.
|
Academic Article
|
Hemifacial spasm: clinical findings and treatment.
|
Academic Article
|
Movement and reaction times and fine coordination tasks following pallidotomy.
|
Academic Article
|
Bilateral hemifacial spasm: a report of five cases and a literature review.
|
Academic Article
|
Basal ganglia neuronal discharge in primary and secondary dystonia.
|
Academic Article
|
Tetrabenazine treatment for tardive dyskinesia: assessment by randomized videotape protocol.
|
Academic Article
|
Effects of visual and auditory cues on gait in individuals with Parkinson's disease.
|
Academic Article
|
Bruxism and cranial-cervical dystonia: is there a relationship?
|
Academic Article
|
Apolipoprotein E controls the risk and age at onset of Parkinson disease.
|
Academic Article
|
Minocycline in Huntington's disease: a pilot study.
|
Academic Article
|
Methods of H-reflex evaluation in the early stages of Parkinson's disease.
|
Academic Article
|
Pramipexole inhibits lipid peroxidation and reduces injury in the substantia nigra induced by the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in C57BL/6 mice.
|
Academic Article
|
The evolution of diagnosis in early Parkinson disease. Parkinson Study Group.
|
Academic Article
|
Intrafamilial phenotypic variability of the DYT1 dystonia: from asymptomatic TOR1A gene carrier status to dystonic storm.
|
Academic Article
|
Botulinum toxin in the treatment of tics.
|
Academic Article
|
Age-dependent dopaminergic dysfunction in Nurr1 knockout mice.
|
Academic Article
|
Gabapentin for essential tremor: a multiple-dose, double-blind, placebo-controlled trial.
|
Academic Article
|
Variability and validity of polymorphism association studies in Parkinson's disease.
|
Academic Article
|
An open-label pilot study of levetiracetam for essential tremor.
|
Academic Article
|
Postural control in Parkinson's disease after unilateral posteroventral pallidotomy.
|
Academic Article
|
Long-term botulinum toxin efficacy, safety, and immunogenicity.
|
Academic Article
|
Efficacy and safety of botulinum type A toxin (Dysport) in cervical dystonia: results of the first US randomized, double-blind, placebo-controlled study.
|
Academic Article
|
Switching from pergolide to pramipexole in patients with Parkinson's disease.
|
Academic Article
|
Movement disorders in Friedreich's ataxia.
|
Academic Article
|
Persistent dystonia possibly induced by flecainide.
|
Academic Article
|
Thalamic deep brain stimulation: effects on the nontarget limbs.
|
Academic Article
|
Camptocormia: pathogenesis, classification, and response to therapy.
|
Academic Article
|
Nitric oxide mediates increased susceptibility to dopaminergic damage in Nurr1 heterozygous mice.
|
Academic Article
|
Modafinil for daytime somnolence in Parkinson's disease: double blind, placebo controlled parallel trial.
|
Academic Article
|
Association study of Parkin gene polymorphisms with idiopathic Parkinson disease.
|
Academic Article
|
Effect of vagal nerve stimulation in a case of Tourette's syndrome and complex partial epilepsy.
|
Academic Article
|
The LRRK2 I2012T, G2019S and I2020T mutations are not common in patients with essential tremor.
|
Academic Article
|
Joint and skeletal deformities in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy.
|
Academic Article
|
Neurologic approach to drug-induced movement disorders: a study of 125 patients.
|
Academic Article
|
Effects of green tea polyphenols on dopamine uptake and on MPP+ -induced dopamine neuron injury.
|
Academic Article
|
Mutations in NR4A2 associated with familial Parkinson disease.
|
Academic Article
|
Runner's dystonia.
|
Academic Article
|
Autopsy-proven Huntington's disease with 29 trinucleotide repeats.
|
Academic Article
|
Randomized, blind, controlled trial of transdermal rotigotine in early Parkinson disease.
|
Academic Article
|
GPi deep brain stimulation for Tourette syndrome improves tics and psychiatric comorbidities.
|
Academic Article
|
Clinical heterogeneity of neurodegeneration with brain iron accumulation (Hallervorden-Spatz syndrome) and pantothenate kinase-associated neurodegeneration.
|
Academic Article
|
Genetic polymorphisms of the N-acetyltransferase genes and risk of Parkinson's disease.
|
Academic Article
|
The effects of subthalamic nucleus deep brain stimulation on parkinsonian tremor.
|
Academic Article
|
The impact of depressive symptoms in early Parkinson disease.
|
Academic Article
|
Short and long-term motor and cognitive outcome of staged bilateral pallidotomy: a retrospective analysis.
|
Academic Article
|
Candidate locus for chorea and tic disorders at 15q?
|
Academic Article
|
Prevention and restoration of lactacystin-induced nigrostriatal dopamine neuron degeneration by novel brain-permeable iron chelators.
|
Academic Article
|
Haplotype analysis of the ETM2 locus in familial essential tremor.
|
Academic Article
|
Focal hand dystonia, mirror dystonia and motor overflow.
|
Academic Article
|
Dopaminergic properties and experimental anti-parkinsonian effects of IPX750 in rodent models of Parkinson disease.
|
Academic Article
|
Bilateral pedunculopontine nuclei strokes presenting as freezing of gait.
|
Academic Article
|
Pramipexole vs levodopa as initial treatment for Parkinson disease: a 4-year randomized controlled trial.
|
Academic Article
|
Five-year follow-up of unilateral posteroventral pallidotomy in Parkinson's disease.
|
Academic Article
|
Long-term treatment with botulinum toxin type A in cervical dystonia has low immunogenicity by mouse protection assay.
|
Academic Article
|
Essential tremor among children.
|
Academic Article
|
Shoulder pain: a presenting symptom of Parkinson disease.
|
Academic Article
|
Neutralizing antibodies in dystonic patients who still respond well to botulinum toxin type A.
|
Academic Article
|
Genetic study of an American family with DYT3 dystonia (lubag).
|
Academic Article
|
Treatment of hypophonia with collagen vocal cord augmentation in patients with parkinsonism.
|
Academic Article
|
Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results.
|
Academic Article
|
Hemidystonia-hemiatrophy syndrome.
|
Academic Article
|
Phenotypic features of Huntington's disease-like 2.
|
Academic Article
|
The course of depressive symptoms in early Parkinson's disease.
|
Academic Article
|
Variable expression of Parkinson's disease: a base-line analysis of the DATATOP cohort. The Parkinson Study Group.
|
Academic Article
|
Motor-phonic tic mimicking essential palatal myoclonus.
|
Academic Article
|
G309D and W437OPA PINK1 mutations in Caucasian Parkinson's disease patients.
|
Academic Article
|
Progressive supranuclear palsy: motor, neurobehavioral, and neuro-ophthalmic findings.
|
Academic Article
|
Atypical parkinsonism and motor neuron syndrome in a Biosphere 2 participant: a possible complication of chronic hypoxia and carbon monoxide toxicity?
|
Academic Article
|
LINGO1 and LINGO2 variants are associated with essential tremor and Parkinson disease.
|
Academic Article
|
Pleuropulmonary fibrosis after long-term treatment with the dopamine agonist pergolide for Parkinson Disease.
|
Academic Article
|
HS1-BP3 gene variant is common in familial essential tremor.
|
Academic Article
|
Tardive dyskinesia and other movement disorders secondary to aripiprazole.
|
Academic Article
|
CSF A?(42) and tau in Parkinson's disease with cognitive impairment.
|
Academic Article
|
Examination of the SGCE gene in Tourette syndrome patients with obsessive-compulsive disorder.
|
Academic Article
|
Premutation alleles associated with Parkinson disease and essential tremor.
|
Academic Article
|
Globus pallidus deep brain stimulation in dystonia.
|
Academic Article
|
Caudate glucose hypometabolism in a subject carrying an unstable allele of intermediate CAG(33) repeat length in the Huntington's disease gene.
|
Academic Article
|
Efficacy and safety of incobotulinumtoxinA (NT 201, Xeomin) in the treatment of blepharospasm-a randomized trial.
|
Academic Article
|
Tourette's syndrome and the law.
|
Academic Article
|
Genetic analysis of the GABRA1 gene in patients with essential tremor.
|
Academic Article
|
Dystonic tics in patients with Tourette's syndrome.
|
Academic Article
|
Exploring the correlates of intermediate CAG repeats in Huntington disease.
|
Academic Article
|
Motor fluctuations and dyskinesias in Parkinson's disease: clinical manifestations.
|
Academic Article
|
Long-term prognosis of patients with psychogenic movement disorders.
|
Academic Article
|
Secondary tics and tourettism.
|
Academic Article
|
Human T-cell responses to botulinum neurotoxin. Responses in vitro of lymphocytes from patients with cervical dystonia and/or other movement disorders treated with BoNT/A or BoNT/B.
|
Academic Article
|
Genetic analysis of parkin co-regulated gene (PACRG) in patients with early-onset parkinsonism.
|
Academic Article
|
Subthalamic deep brain stimulation with a constant-current device in Parkinson's disease: an open-label randomised controlled trial.
|
Academic Article
|
Long-term safety and tolerability of rotigotine transdermal system in patients with early-stage idiopathic Parkinson's disease: a prospective, open-label extension study.
|
Academic Article
|
Extended study of A265G variant of HS1BP3 in essential tremor and Parkinson disease.
|
Academic Article
|
Genetic analysis of LRRK2 mutations in patients with Parkinson disease.
|
Academic Article
|
Mutation screening of the HTR2B gene in patients with Tourette syndrome.
|
Academic Article
|
Comparing knowledge and attitudes towards genetic testing in Parkinson's disease in an American and Asian population.
|
Academic Article
|
The coexistence of tics and dystonia.
|
Academic Article
|
Spinocerebellar ataxia types 2 and 10: more than a coincidental association?
|
Academic Article
|
Genetics of essential tremor.
|
Academic Article
|
The spectrum of movement disorders in children with anti-NMDA receptor encephalitis.
|
Academic Article
|
Long-term evaluation of deep brain stimulation of the thalamus.
|
Academic Article
|
A founding LRRK2 haplotype shared by Tunisian, US, European and Middle Eastern families with Parkinson's disease.
|
Academic Article
|
Stiff-person syndrome: an autoimmune disease.
|
Academic Article
|
Orthostatic tremor: an association with essential tremor.
|
Academic Article
|
Lower body parkinsonism: evidence for vascular etiology.
|
Academic Article
|
A functional variant of the dopamine D3 receptor is associated with risk and age-at-onset of essential tremor.
|
Academic Article
|
Exploring the relationship between essential tremor and Parkinson's disease.
|
Academic Article
|
Is history of depression a contraindication to treatment with tetrabenazine?
|
Academic Article
|
Botulinum toxin injection for congenital muscular torticollis presenting in children and adults.
|
Academic Article
|
Short-term effects of tetrabenazine on chorea associated with Huntington's disease.
|
Academic Article
|
Examination of the SLITRK1 gene in Caucasian patients with Tourette syndrome.
|
Academic Article
|
Screening for Lrrk2 G2019S and clinical comparison of Tunisian and North American Caucasian Parkinson's disease families.
|
Academic Article
|
Cognitive declines following bilateral subthalamic nucleus deep brain stimulation for the treatment of Parkinson's disease.
|
Academic Article
|
Clinico-immunologic aspects of botulinum toxin type B treatment of cervical dystonia.
|
Academic Article
|
G2019S mutation in the leucine-rich repeat kinase 2 gene is not associated with multiple system atrophy.
|
Academic Article
|
Essential tremor: clinical correlates in 350 patients.
|
Academic Article
|
Short-term and long-term safety of deep brain stimulation in the treatment of movement disorders.
|
Academic Article
|
Genetic analysis of LRRK2 P755L variant in Caucasian patients with Parkinson's disease.
|
Academic Article
|
Distinguishing psychogenic and essential tremor.
|
Academic Article
|
Hereditary chin tremor in Parkinson's disease.
|
Academic Article
|
Alexia without agraphia in Creutzfeldt-Jakob disease.
|
Academic Article
|
Impulse control disorders and pathological gambling in patients with Parkinson disease.
|
Academic Article
|
Comparison of neuroprotective and neurorestorative capabilities of rasagiline and selegiline against lactacystin-induced nigrostriatal dopaminergic degeneration.
|
Academic Article
|
Potential outcome measures and trial design issues for multiple system atrophy.
|
Academic Article
|
Mozart's movements and behaviour: a case of Tourette's syndrome?
|
Academic Article
|
Hyperhidrosis due to deep brain stimulation in a patient with essential tremor. Case report.
|
Academic Article
|
Intrathecal baclofen for intractable axial dystonia.
|
Academic Article
|
A study of chorea after tetrabenazine withdrawal in patients with Huntington disease.
|
Academic Article
|
CSF multianalyte profile distinguishes Alzheimer and Parkinson diseases.
|
Academic Article
|
Nurr1 deficiency predisposes to lactacystin-induced dopaminergic neuron injury in vitro and in vivo.
|
Academic Article
|
Decreased NURR1 gene expression in patients with Parkinson's disease.
|
Academic Article
|
A randomized, double-blind, placebo-controlled, delayed start study to assess rasagiline as a disease modifying therapy in Parkinson's disease (the ADAGIO study): rationale, design, and baseline characteristics.
|
Academic Article
|
Applause sign in Parkinsonian disorders and Huntington's disease.
|
Academic Article
|
Relationship between various clinical outcome assessments in patients with blepharospasm.
|
Academic Article
|
Coprophenomena in Tourette syndrome.
|
Academic Article
|
Atomoxetine for freezing of gait in Parkinson disease.
|
Academic Article
|
Spinocerebellar ataxia 8: variable phenotype and unique pathogenesis.
|
Academic Article
|
Lrrk2 R1441G-related Parkinson's disease: evidence of a common founding event in the seventh century in Northern Spain.
|
Academic Article
|
Botulinum toxin treatment of cranial-cervical dystonia, spasmodic dysphonia, other focal dystonias and hemifacial spasm.
|
Academic Article
|
Transcription factor PITX3 gene in Parkinson's disease.
|
Academic Article
|
GIGYF2 Asn56Ser and Asn457Thr mutations in Parkinson disease patients.
|
Academic Article
|
Motor overflow and mirror dystonia.
|
Academic Article
|
Impact of STN-DBS on life and health satisfaction in patients with Parkinson's disease.
|
Academic Article
|
Efficacy and tolerability of pregabalin in essential tremor: a randomized, double-blind, placebo-controlled, crossover trial.
|
Academic Article
|
Relationship between neuropsychological outcome and DBS surgical trajectory and electrode location.
|
Academic Article
|
A double-blind, delayed-start trial of rasagiline in Parkinson's disease.
|
Academic Article
|
Epidemiology and management of essential tremor in children.
|
Academic Article
|
A randomised, double-blind, placebo-controlled study of topiramate in the treatment of Tourette syndrome.
|
Academic Article
|
Occupation and risk of parkinsonism: a multicenter case-control study.
|
Academic Article
|
Clinical efficacy and tolerability of Xeomin in the treatment of blepharospasm.
|
Academic Article
|
Multiple LRRK2 variants modulate risk of Parkinson disease: a Chinese multicenter study.
|
Academic Article
|
Long-term efficacy and safety of botulinum toxin type A (Dysport) in cervical dystonia.
|
Academic Article
|
Tourette's syndrome in adults.
|
Academic Article
|
Dramatic response of facial stereotype/tic to tetrabenazine in the first reported cases of neuroferritinopathy in the United States.
|
Academic Article
|
Gene delivery of AAV2-neurturin for Parkinson's disease: a double-blind, randomised, controlled trial.
|
Academic Article
|
Initiating levodopa/carbidopa therapy with and without entacapone in early Parkinson disease: the STRIDE-PD study.
|
Academic Article
|
Cognitive outcome and reliable change indices two years following bilateral subthalamic nucleus deep brain stimulation.
|
Academic Article
|
Proteasome inhibition modeling nigral neuron degeneration in Parkinson's disease.
|
Academic Article
|
Essential tremor quantification during activities of daily living.
|
Academic Article
|
Human T-cell responses to botulinum neurotoxin: proliferative responses in vitro of lymphocytes from botulinum neurotoxin A-treated movement disorder patients.
|
Academic Article
|
Lesch-Nyhan syndrome: a study of motor behavior and cerebrospinal fluid neurotransmitters.
|
Academic Article
|
LINGO1 rs9652490 variant in Parkinson disease patients.
|
Academic Article
|
Perampanel, an AMPA antagonist, found to have no benefit in reducing "off" time in Parkinson's disease.
|
Academic Article
|
Clinical, biochemical, and neuropathologic findings following transplantation of adrenal medulla to the caudate nucleus for treatment of Parkinson's disease.
|
Academic Article
|
Head injury, a-synuclein Rep1, and Parkinson's disease.
|
Academic Article
|
The association of Tourette syndrome and dopa-responsive dystonia.
|
Academic Article
|
Systematic genetic analysis of the PITX3 gene in patients with Parkinson disease.
|
Academic Article
|
A double-blind, delayed-start trial of rasagiline in Parkinson's disease (the ADAGIO study): prespecified and post-hoc analyses of the need for additional therapies, changes in UPDRS scores, and non-motor outcomes.
|
Academic Article
|
Peripheral trauma and movement disorders: a systematic review of reported cases.
|
Academic Article
|
Changes in cognitive-emotional and physiological symptoms of depression following STN-DBS for the treatment of Parkinson's disease.
|
Academic Article
|
The prevalence of symptomatic orthostatic hypotension in patients with Parkinson's disease and atypical parkinsonism.
|
Academic Article
|
Respiratory disorders associated with dystonia.
|
Academic Article
|
Convergence spasm in conversion disorders: prevalence in psychogenic and other movement disorders compared with controls.
|
Academic Article
|
Reflexive and volitional saccades: biomarkers of Huntington disease severity and progression.
|
Academic Article
|
Rationale and design of a prospective study: Cervical Dystonia Patient Registry for Observation of OnaBotulinumtoxinA Efficacy (CD PROBE).
|
Academic Article
|
Dystonia in musicians.
|
Academic Article
|
Metoclopramide-induced movement disorders. Clinical findings with a review of the literature.
|
Academic Article
|
Hemiballism-hemichorea. Clinical and pharmacologic findings in 21 patients.
|
Academic Article
|
Deep brain stimulation hardware complications in patients with movement disorders: risk factors and clinical correlations.
|
Academic Article
|
Mutations in the gene PRRT2 cause paroxysmal kinesigenic dyskinesia with infantile convulsions.
|
Academic Article
|
How to identify tremor dominant and postural instability/gait difficulty groups with the movement disorder society unified Parkinson's disease rating scale: comparison with the unified Parkinson's disease rating scale.
|
Academic Article
|
Yips and other movement disorders in golfers.
|
Academic Article
|
The VPS35 gene and Parkinson's disease.
|
Academic Article
|
Tardive dystonia in patients with Tourette's syndrome.
|
Academic Article
|
Case 2, 1988. Congenital mental retardation and juvenile parkinsonism.
|
Academic Article
|
Etiology and differential diagnosis of blepharospasm and oromandibular dystonia.
|
Academic Article
|
Blepharospasm and cranial-cervical dystonia (Meige's syndrome): familial occurrence.
|
Academic Article
|
A comparison of postspace-flight orthostatic intolerance to vasovagal syncope and autonomic failure and the potential use of the alpha agonist midodrine for these conditions.
|
Academic Article
|
Botulinum toxin in the treatment of dystonic tics.
|
Academic Article
|
CAG repeat size and clinical presentation in Huntington's disease.
|
Academic Article
|
Use of botulinum toxin in the treatment of hand dystonia.
|
Academic Article
|
Hereditary motor-sensory neuropathy and movement disorders.
|
Academic Article
|
Deprenyl in attention deficit associated with Tourette's syndrome.
|
Academic Article
|
Cocaine-related movement disorders.
|
Academic Article
|
Molecular detection of new mutations, resolution of ambiguous results and complex genetic counseling issues in Huntington disease.
|
Academic Article
|
Posteroventral medial pallidotomy in levodopa-unresponsive parkinsonism.
|
Academic Article
|
Symptomatic and functional outcome of surgical treatment of cervical dystonia.
|
Academic Article
|
Assessment of motor function after stereotactic pallidotomy.
|
Academic Article
|
Post-traumatic movement disorders: effect of the legal system on outcome.
|
Academic Article
|
Mouse bioassay versus Western blot assay for botulinum toxin antibodies: correlation with clinical response.
|
Academic Article
|
Attitudes toward neurosurgical procedures for Parkinson's disease and obsessive-compulsive disorder.
|
Academic Article
|
Bilineal transmission in Tourette syndrome.
|
Academic Article
|
Re-emergent tremor of Parkinson's disease.
|
Academic Article
|
Reduced Nurr1 expression increases the vulnerability of mesencephalic dopamine neurons to MPTP-induced injury.
|
Academic Article
|
The alpha-synuclein gene is not a major risk factor in familial Parkinson disease.
|
Academic Article
|
Treating severe bruxism with botulinum toxin.
|
Academic Article
|
Effects of pallidotomy on gait and balance.
|
Academic Article
|
Acoustic reflex abnormalities in cranial-cervical dystonia.
|
Academic Article
|
Identification of a high frequency of mutation at exon 8 of the ATP7B gene in a Chinese population with Wilson disease by fluorescent PCR.
|
Academic Article
|
Low body weight in Parkinson's disease.
|
Academic Article
|
A double-blind, placebo-controlled and longitudinal study of riluzole in early Parkinson's disease.
|
Academic Article
|
Substantia nigra lesions in viral encephalitis.
|
Academic Article
|
Soleus H-reflex measures in patients with focal and generalized dystonia.
|
Academic Article
|
Comparison of efficacy and immunogenicity of original versus current botulinum toxin in cervical dystonia.
|
Academic Article
|
Screening for mutations in the MECP2 (Rett syndrome) gene in Gilles de la Tourette syndrome.
|
Academic Article
|
MDMA and Parkinsonism.
|
Academic Article
|
Glutathione S-transferase omega-1 modifies age-at-onset of Alzheimer disease and Parkinson disease.
|
Academic Article
|
Hearing impairment in essential tremor.
|
Academic Article
|
Migraine headache in patients with Tourette syndrome.
|
Academic Article
|
Premonitory sensory phenomenon in Tourette's syndrome.
|
Academic Article
|
Clinical gait and balance scale (GABS): validation and utilization.
|
Academic Article
|
Metoclopramide-induced tardive dyskinesia in an infant.
|
Academic Article
|
Glabellar and palmomental reflexes in Parkinsonian disorders.
|
Academic Article
|
Clinical correlates of response to botulinum toxin injections.
|
Academic Article
|
Genetic and clinical identification of Parkinson's disease patients with LRRK2 G2019S mutation.
|
Academic Article
|
Autonomic function after botulinum toxin type A or B: a double-blind, randomized trial.
|
Academic Article
|
Nurr1 in Parkinson's disease and related disorders.
|
Academic Article
|
Heterogeneous phenotype in a family with compound heterozygous parkin gene mutations.
|
Academic Article
|
Gene dosage analysis of alpha-synuclein (SNCA) in patients with Parkinson's disease.
|
Academic Article
|
Genomewide scans in North American families reveal genetic linkage of essential tremor to a region on chromosome 6p23.
|
Academic Article
|
Psychogenic tremor: long-term outcome.
|
Academic Article
|
Sulpiride-induced tardive dystonia.
|
Academic Article
|
Long-term tolerability of tetrabenazine in the treatment of hyperkinetic movement disorders.
|
Academic Article
|
Adult onset tics after peripheral injury.
|
Academic Article
|
Prevalence of cervical dystonia and spasmodic torticollis in the United States general population.
|
Academic Article
|
Transdermal rotigotine: double-blind, placebo-controlled trial in Parkinson disease.
|
Academic Article
|
Malignant Tourette syndrome.
|
Academic Article
|
The other Babinski sign in hemifacial spasm.
|
Academic Article
|
Overnight switch from oral dopaminergic agonists to transdermal rotigotine patch in subjects with Parkinson disease.
|
Academic Article
|
Hemiparkinsonism-hemiatrophy syndrome.
|
Academic Article
|
Mutation analysis of the parkin and PINK1 genes in American Caucasian early-onset Parkinson disease families.
|
Academic Article
|
Cervical dystonia: clinical findings and associated movement disorders.
|
Academic Article
|
Neuroprotection of rapamycin in lactacystin-induced neurodegeneration via autophagy enhancement.
|
Academic Article
|
Psychogenic movement disorders in children.
|
Academic Article
|
Depressed mood and memory impairment before and after unilateral posteroventral pallidotomy in Parkinson's disease.
|
Academic Article
|
Genetic analysis of the NEUROG2 gene in patients with Parkinson's disease.
|
Academic Article
|
Examination of the MSX1 gene in patients with Parkinson's disease.
|
Academic Article
|
DJ-1 and alpha-synuclein in human cerebrospinal fluid as biomarkers of Parkinson's disease.
|
Academic Article
|
Botulinum toxin injections for cervical dystonia.
|
Academic Article
|
Significance and confounders of peripheral DJ-1 and alpha-synuclein in Parkinson's disease.
|
Academic Article
|
Correlation between Kinesia system assessments and clinical tremor scores in patients with essential tremor.
|
Academic Article
|
Asian over-representation among patients with hemifacial spasm compared to patients with cranial-cervical dystonia.
|
Academic Article
|
Complement 3 and factor h in human cerebrospinal fluid in Parkinson's disease, Alzheimer's disease, and multiple-system atrophy.
|
Academic Article
|
Transcutaneous electrical stimulation (TENS) for psychogenic movement disorders.
|
Academic Article
|
Efficacy and safety of incobotulinumtoxinA (NT 201, XEOMIN?, botulinum neurotoxin type A, without accessory proteins) in patients with cervical dystonia.
|
Academic Article
|
Alternating verbal fluency performance following bilateral subthalamic nucleus deep brain stimulation for Parkinson's disease.
|
Academic Article
|
Reliability of a new scale for essential tremor.
|
Academic Article
|
Analysis of CYP2D6 genotype and response to tetrabenazine.
|
Academic Article
|
Characterization of the Huntington intermediate CAG repeat expansion phenotype in PHAROS.
|
Concept
|
Male
|
Academic Article
|
Sustained efficacy and safety of repeated incobotulinumtoxinA (Xeomin(?)) injections in blepharospasm.
|
Academic Article
|
Bilateral globus pallidus internus deep brain stimulation after bilateral pallidotomy in a patient with generalized early-onset primary dystonia.
|
Academic Article
|
Flu-like symptoms and associated immunological response following therapy with botulinum toxins.
|
Academic Article
|
The safety and efficacy of thalamic deep brain stimulation in essential tremor: 10 years and beyond.
|
Academic Article
|
Deep brain stimulation of the subthalamic nucleus for peripherally induced parkinsonism.
|
Academic Article
|
Randomized trial of IPX066, carbidopa/levodopa extended release, in early Parkinson's disease.
|
Academic Article
|
Long-term efficacy and safety of fluphenazine in patients with Tourette syndrome.
|
Academic Article
|
The clinical features of psychogenic movement disorders resembling tics.
|
Academic Article
|
Symptomatic efficacy of rasagiline monotherapy in early Parkinson's disease: post-hoc analyses from the ADAGIO trial.
|
Academic Article
|
Cervical dystonia and pain: characteristics and treatment patterns from CD PROBE (Cervical Dystonia Patient Registry for Observation of OnabotulinumtoxinA Efficacy).
|
Academic Article
|
Alleviating manoeuvres (sensory tricks) in cervical dystonia.
|
Academic Article
|
Neurohistopathological findings at the electrode-tissue interface in long-term deep brain stimulation: systematic literature review, case report, and assessment of stimulation threshold safety.
|
Academic Article
|
Copy number variation in obsessive-compulsive disorder and tourette syndrome: a cross-disorder study.
|
Academic Article
|
Bilateral pallidal deep brain stimulation for X-linked dystonia-parkinsonism.
|
Academic Article
|
Peptidoglycan recognition protein genes and risk of Parkinson's disease.
|
Academic Article
|
Randomized trial of IV valproate vs metoclopramide vs ketorolac for acute migraine.
|
Academic Article
|
Cross-disorder genome-wide analyses suggest a complex genetic relationship between Tourette's syndrome and OCD.
|
Academic Article
|
IncobotulinumtoxinA (Xeomin?) injected for blepharospasm or cervical dystonia according to patient needs is well tolerated.
|
Academic Article
|
Effects of long-term treatment with rotigotine transdermal system on dyskinesia in patients with early-stage Parkinson's disease.
|
Academic Article
|
Epigenetic mechanisms in Parkinson's disease.
|
Academic Article
|
Primary results from the cervical dystonia patient registry for observation of onabotulinumtoxina efficacy (CD PROBE).
|
Academic Article
|
Stiff-person syndrome: insights into a complex autoimmune disorder.
|
Academic Article
|
Bolivian kindred with combined spinocerebellar ataxia types 2 and 10.
|
Academic Article
|
Natural history of multiple system atrophy in the USA: a prospective cohort study.
|
Academic Article
|
A Pilot Study of a Cognitive-Behavioral Treatment for Anxiety and Depression in Patients With Parkinson Disease.
|
Academic Article
|
Gene delivery of neurturin to putamen and substantia nigra in Parkinson disease: A double-blind, randomized, controlled trial.
|
Academic Article
|
Dopamine transporter imaging in essential tremor with and without parkinsonian features.
|
Academic Article
|
Speech and voice disorders in patients with psychogenic movement disorders.
|
Academic Article
|
Diffusion imaging of nigral alterations in early Parkinson's disease with dopaminergic deficits.
|
Academic Article
|
Clinical-Genetic Associations in the Prospective Huntington at Risk Observational Study (PHAROS): Implications for Clinical Trials.
|
Academic Article
|
Whole-Exome Sequencing in Familial Parkinson Disease.
|
Academic Article
|
Submolecular recognition of the C-terminal domain of the heavy chain of botulinum neurotoxin type A by T cells from toxin-treated cervical dystonia patients.
|
Academic Article
|
Clinimetric testing of the comprehensive cervical dystonia rating scale.
|
Academic Article
|
Drug-Induced Dyskinesia, Part 2: Treatment of Tardive Dyskinesia.
|
Academic Article
|
Identification of TMEM230 mutations in familial Parkinson's disease.
|
Academic Article
|
Effect of Deutetrabenazine on Chorea Among Patients With Huntington Disease: A Randomized Clinical Trial.
|
Academic Article
|
Psychogenic Ophthalmologic Movement Disorders.
|
Academic Article
|
Neuropsychological outcomes from constant current deep brain stimulation for Parkinson's disease.
|
Academic Article
|
Submolecular recognition regions of the HN domain of the heavy chain of botulinum neurotoxin type A by T cells from toxin-treated cervical dystonia patients.
|
Academic Article
|
A randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington disease.
|
Academic Article
|
Assessment of Safety and Efficacy of Safinamide as a Levodopa Adjunct in Patients With Parkinson Disease and Motor Fluctuations: A Randomized Clinical Trial.
|
Academic Article
|
Distinguishing features of psychogenic (functional) versus organic hemifacial spasm.
|
Academic Article
|
Examiner manoeuvres 'sensory tricks' in functional (psychogenic) movement disorders.
|
Academic Article
|
Understanding falls in progressive supranuclear palsy.
|
Academic Article
|
Treatment of blepharospasm with apraclonidine.
|
Academic Article
|
Thalamic DBS with a constant-current device in essential tremor: A?controlled clinical trial.
|
Academic Article
|
Apraclonidine in the treatment of ptosis.
|
Academic Article
|
Psychiatric associations of adult-onset focal dystonia phenotypes.
|
Academic Article
|
ADCY5-related movement disorders: Frequency, disease course and phenotypic variability in a cohort of paediatric patients.
|
Academic Article
|
Functional (psychogenic) stereotypies.
|
Academic Article
|
Safety of Converting From Tetrabenazine to Deutetrabenazine for the Treatment of Chorea.
|
Academic Article
|
Excessive burden of lysosomal storage disorder gene variants in Parkinson's disease.
|
Academic Article
|
The Regions on the Light Chain of Botulinum Neurotoxin Type A Recognized by T Cells from Toxin-Treated Cervical Dystonia Patients. The Complete Human T-Cell Recognition Map of the Toxin Molecule.
|
Academic Article
|
Leg stereotypy syndrome: phenomenology and prevalence.
|
Academic Article
|
Onabotulinum toxin-A injections for sleep bruxism: A double-blind, placebo-controlled study.
|
Academic Article
|
Cervical dystonia and substance abuse.
|
Academic Article
|
Consensus for the measurement of the camptocormia angle in the standing patient.
|
Academic Article
|
Safety and Tolerability of Multiple Ascending Doses of PRX002/RG7935, an Anti-a-Synuclein Monoclonal Antibody, in Patients With Parkinson Disease: A Randomized Clinical Trial.
|
Academic Article
|
Local field potentials of subthalamic nucleus contain electrophysiological footprints of motor subtypes of Parkinson's disease.
|
Academic Article
|
Ecopipam, a D1 receptor antagonist, for treatment of tourette syndrome in children: A randomized, placebo-controlled crossover study.
|
Academic Article
|
Botulinum Toxin for the Treatment of Hand Tremor.
|
Academic Article
|
Benefits and risks of unilateral and bilateral ventral intermediate nucleus deep brain stimulation for axial essential tremor symptoms.
|
Academic Article
|
Real-World Experience With VMAT2 Inhibitors.
|
Academic Article
|
Predictors of alcohol responsiveness in dystonia.
|
Academic Article
|
Parkinson's disease age at onset genome-wide association study: Defining heritability, genetic loci, and a-synuclein mechanisms.
|
Academic Article
|
Head tremor at disease onset: an ataxic phenotype of cervical dystonia.
|
Academic Article
|
Autosomal dominant mitochondrial membrane protein-associated neurodegeneration (MPAN).
|
Academic Article
|
Clinical phenotype in carriers of intermediate alleles in the huntingtin gene.
|
Academic Article
|
Young-onset Parkinson's disease: Its unique features and their impact on quality of life.
|
Academic Article
|
Hypertension and progressive supranuclear palsy.
|
Academic Article
|
Minimal clinically important change in patients with cervical dystonia: Results from the CD PROBE study.
|
Academic Article
|
Functional gait disorders, clinical phenomenology, and classification.
|
Academic Article
|
EASE LID 2: A 2-Year Open-Label Trial of Gocovri (Amantadine) Extended Release for Dyskinesia in Parkinson's Disease.
|
Academic Article
|
Postural Directionality and Head Tremor in Cervical Dystonia.
|
Academic Article
|
Understanding the relationship between freezing of gait and other progressive supranuclear palsy features.
|
Academic Article
|
Clinical and Demographic Characteristics of Upper Limb Dystonia.
|
Academic Article
|
Dystonia and Tremor: A Cross-Sectional Study of the Dystonia Coalition Cohort.
|
Academic Article
|
Quantitative mobility measures complement the MDS-UPDRS for characterization of Parkinson's disease heterogeneity.
|
Academic Article
|
Botulinum Neurotoxin Injections in Childhood Opisthotonus.
|
Academic Article
|
Clinical-Instrumental patterns of neurodegeneration in Essential Tremor: A data-driven approach.
|
Academic Article
|
Diagnostic criteria for blepharospasm: A multicenter international study.
|
Academic Article
|
Safety and Efficacy of Flexible-Dose Deutetrabenazine in Children and Adolescents With Tourette Syndrome: A Randomized Clinical Trial.
|
Academic Article
|
Efficacy and Safety of Fixed-Dose Deutetrabenazine in Children and Adolescents for Tics Associated With Tourette Syndrome: A Randomized Clinical Trial.
|
Academic Article
|
Association of Essential Tremor With Novel Risk Loci: A Genome-Wide Association Study and Meta-analysis.
|
Academic Article
|
COVID19-associated new-onset movement disorders: a follow-up study.
|
Academic Article
|
Contrasting features between Tourette syndrome and secondary tic disorders.
|